ARCHIVES

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

This article is from The Cancer Letter archive.

Vol. 36 No. 42 | November 19, 2010

Download PDF Visit The Full Archive

Related Articles

DCCP Board Approves Concept Of RFA, New, Competing Contracts

October 15, 1982

Steckel Urges AACI to seek Increase In Core Funding

July 17, 1981

Hybridoma Cell Lines Available from NCI

September 3, 1982

With $1.1 Billion At Stake, Cancer Groups Mull Comparative Effectiveness Studies

May 22, 2009

NCI Cooperative Group Trials Approved Last Month By CTEP

March 26, 2010

FDA Rejects Genentech Bid For Accelerated Approval For T-DM1. NCI Breaks Ground For Satellite Campus At Shady Grove

September 3, 2010